August 2017 Volume 13, Issue 8
Volume 13, Issue 8 | August 2017
August 2017
In this Issue
Research & Development
A polymerase-free paper
Quanterix, DestiNA Genomics publish study on new method for detecting liver tox biomarkersInhibiting varicella-zoster
NanoViricides drug candidates reduce extent of shingles virus infection of human skinExpansion and partnering in stem cells
MilliporeSigma expands deal with Public Health England and teams with Elsevier for ReaxysTwo are better than one
KaLy-Cell and CiToxLAB join forces to offer in-vitro and ex-vivo testing for hepatotoxicity and metabolismStrategic alliance on plasmid DNA drugs extended
Alma Bio Therapeutics and Delphi Genetics aim to rein in uncontrolled inflammation in autoimmune diseasesDiscovery
Answers for Alzheimer’s
Risk of developing AD is linked to a network of genes associated with myeloid cellsThe match game
NCCU finds home for orphan diabetes drugs in the prevention of breast cancerEnding the runaround with RNA
Earlham Institute and NEB tackle challenging RNA with new library prep kitPartners in ‘ORBIT’ around glioblastoma multiforme
Heptares announces collaboration with NYU to seek brain cancer treatmentsProMIS identifies epitope target for ALS and dementia
Company files patent application for novel target identified on misfolded forms of the protein TDP43Clinical Trials
A look behind and ahead
SCORR and Applied Clinical Trials release report on past and pending change for clinical trialsAn analgesic with ‘significant potential’
Encouraging top-line results seen with CR845 pain relief trial in osteoarthritis patientsA double triple for June
TG Therapeutics presents triple combination regimen data from two trialsAnalyzing the microenvironment
Researchers define glioblastoma ecosystem for more effective immunotherapy trialsMoving forward on SMA
Cytokinetics announces baseline data from first cohort of Phase 2 trial in patients with spinal muscular atrophyEditor's Focus
Of a mind to decode the mind
There are still many gaps in our knowledge when it comes to how the brain works, despite how many people are affected by mental image, but efforts are underway to try and close those gaps a step at a timeCommentary
The amateur scientist
As knowledge becomes more available and science more complicated, the line between amateurs and experts can seem blurred; scientists are expected to have all the answers, and those answers are supposed to be simultaneously accessible and titillatingAn open letter to the biopharma community
As gender disparity continues in STEM fields, life-sciences industry leaders released an open letter to encourage gender diversity and offer guidelines for hiring practicesFeature
Show Preview: A showcase for European life sciences
Annual congress seeks to bridge the worlds of science and businessSpecial Reports
Special Report on StemCells/Cell Therapy: Skin in the game
Cell therapy meets gene therapy to advance dermatologyContract Services
Gotta catch ‘em all!
Lonza acquires several companies in the first half of 2017INC’s Japan presence expands with new office
New office will allow for global CRO to continue to support rapid growth in Asia-Pacific’s largest pharmaceutical marketBefore the trials come
The Jackson Laboratory and Crown Bioscience announce global preclinical research agreementDiagnostics
Bolstering biomarker use
New Avant Diagnostics CEO wants to integrate precision diagnostics to treatmentA ‘gem’ of a partnership
Genoptix and Bionano to use Saphyr System to develop hematologic cancer diagnosticsDouble-dose of CDx
Cancer Genetics launches companion diagnostic; Illumina announces NGS kit for CDxPreclinical
Knockout mice guide future autism therapies
Shank3B mice that mimic typical autism behaviors provide a valuable research tool, according to preclinical trialsTaking down Zika
Inovio and TechnoVax edge closer to a functional Zika vaccineAlzheimer’s candidate off to a good start
QR Pharma presents data at AAIC showing preclinical efficacy for PosiphenCompugen presents COM701 combination data at ASCO
Clinical advisory meeting held in preparation for COM701 clinical studies anticipated to begin next yearBusiness & Government Policy
Elsevier launches The Hive 2017
Applications for showcase of pharma and biotech startup innovation close at end of AugustBioTek responds to Paris Climate Accord decision
Company also announces a site expansion and new product updateOn the cutting edge
A roundup of instrumentation, software and other tools and technology newsSubscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe